How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NX

NASDAQ:NXL
Get a brief AI stock analysisSaves ~ 15 minutes of your time

NX

Nexalin Technology IncNASDAQ NXL Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is NXL undervalued compared to its fair value?

The fair value of NXL stock is hidden USD. Relative to the market price of 1.33 USD Nexalin Technology Inc is hidden.

Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California. The company went IPO on 2022-09-16. The firm has developed an easy-to-administer medical...[More about valuation]

Nexalin Technology Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.009 $B

Price:

1.33 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.31

FINANCIALS

Nexalin Technology financial for reporting period

Income Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0024 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0023 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0 B 100%
-0.0024 B -12100%
-0.0023 B -11500%

Balance Sheet

0.0044 B
0.0032 B

Financial Position Analysis

Assets

0.0044 B
Current Assets
0.0043 B
Total non-current assets
0.0002 B

Total current liabilities
0.0012 B
Total non-current liabilities

Cash Flow Statement

-0.0007 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0007 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Nexalin Technology fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-105 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
1450 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-80 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is NXL attractive for investment based on fundamental analysis?

NXL stock rating is hidden. Nexalin Technology is a hidden by Eyestock methodology.

Get NXL Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-3 538

Gross Margin:

77

CFO / Debt ratio:

hidden

Current ratio:

4.101

Debt / Equity ratio:

0.126

ROE:

-105

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

NXL analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for NXL to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Nexalin Technology Inc competitors

AB

ABT

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Par...

Discover

IS

ISRG

Intuitive Surgical Inc

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company i...

Discover

SY

SYK

Stryker Corp

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. The company is ...

Discover

Nexalin Technology Inc dividends

NXL dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About NXL stock

About the company Nexalin Technology Inc

Market cap $B

0.009

Dividend yield

Shares outstanding

7.279961 B

Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California. The company went IPO on 2022-09-16. The firm has developed an easy-to-administer medical device, Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. The company is also designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer’s disease and dementia. The firm's products are non-invasive and undetectable and can provide relief to those afflicted with mental health issues without adverse side effects. Its design of varying voltages, currents, electromagnetic fields and various frequencies called as waveform. The Company’s devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head.

NXL profile

  • Ticker

    NXL

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    16 September 2022

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

    2

  • City

    Laguna Niguel

  • Address

    26072 Merit Circle, Suite 106

  • Cusip

    65345B201